Publications by authors named "Beom-Jun Kwon"
Article Synopsis
- Plants serve as a cost-effective pharmaceutical platform with low contamination risks, but their use for medical treatments faces challenges like allergic reactions to foreign proteins.
- Researchers developed a plant-based version of dupilumab called Dup-scFv, which shows promise for local delivery in treating allergic and autoimmune diseases without systemic side effects.
- Tests indicated that Dup-scFv is effective in reducing inflammation in human nasal cells and has better tissue permeability than traditional dupilumab, suggesting that plant-produced therapies could be a viable option for non-invasive treatments.
Objective: There are few existing data on the status of coronary artery disease (CAD) in patients with atherosclerosis of the cerebral artery detected by brain imaging studies. We aimed to analyze the predictors of asymptomatic angiographically significant CAD detected by simultaneous cerebral and coronary angiography.
Methods: This retrospective cohort study screened data obtained between August 2009 and April 2019; 11,047 patients underwent cerebral angiography for atherosclerotic change (>50% stenosis or aneurysm) seen in brain magnetic resonance angiography (MRA) or computed tomography angiography (CTA) at a single center by endovascular neurosurgeon's decision.